Axq Capital »

Bridgebio Oncology Therapeut shares owned by Axq Capital

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut (BBOT) shares owned by Axq Capital from 13F filings

Historical chart of Axq Capital investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Axq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Axq Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $155k 17k 8.95

More positions owned by Axq Capital

Boston Scientific Corporation (BSX)
Cleveland-cliffs (CLF)
Otis Worldwide Corp (OTIS)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Blackrock (BLK)
Ford Motor Company (F)
TPG Com Cl A (TPG)
Dollar Tree (DLTR)
3M Company (MMM)
Antero Midstream Corp antero midstream (AM)
Rocket Cos Com Cl A (RKT)
TransDigm Group Incorporated (TDG)
Insulet Corporation (PODD)
Wec Energy Group (WEC)
Colgate-Palmolive Company (CL)

View all positions for Axq Capital

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
EcoR1 Capital
Alphabet
Enavate Sciences GP
Citadel Advisors
Paradigm Biocapital Advisors
BlackRock
Novo A/S
Laurion Capital Management
Adage Capital Partners GP
Eventide Asset Management
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut